Skip to main content
Equibles

Savant Capital, LLC

Position in HLN — Haleon plc

CIK 1482880 ROCKFORD, IL
Back to HLN Full portfolio

Position in HLN

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$3,650,801
+$2,447,219 QoQ
Shares Held
391,297
+225.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#84
of 642 holders
Holding Since
Jun 2023
10 quarters on record
Voting authority Sole 92% Shared 5% None 4%

Common Shares in HLN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Savant Capital, LLC holds $13,041,183 across 15 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (28.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HLN
Haleon plc
This page 		391,297 $3,650,801
2 UTHR
UNITED THERAPEUTICS Corp
 3,845 $2,083,336
3 VTRS
Viatris Inc
 74,919 $1,189,713
4 KNSA
Kiniksa Pharmaceuticals International, plc
 15,478 $989,818
5 TAK
Takeda Pharmaceutical Co Ltd
 56,536 $906,272
6 NBIX
Neurocrine Biosciences Inc
 5,342 $900,340
7 LNTH
Lantheus Holdings, Inc.
 7,965 $883,637
8 ZTS
Zoetis Inc.
 9,906 $711,845

All Filings in HLN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,650,801 391,297
2026-03-31 $1,203,582 120,238
2025-12-31 $1,144,735 113,228
2025-09-30 $247,410 27,582
2025-06-30 $798,127 76,965
2025-03-31 $309,296 30,058
2024-12-31 $251,789 26,393
2024-09-30 $140,195 13,251
2023-09-30 $123,317 14,804
2023-06-30 $96,990 11,574